Colorectal Neoplasms Clinical Trial
Official title:
The Feasibility and Acceptability of a Psychosocial Intervention for Advanced Colorectal Cancer Patients
Studies have reported about one-third to half of advanced cancer patients experience psychological distress yet the mental healthcare needs of these patients are not properly assessed and addressed. Patients with advanced colorectal cancer can face unique challenges that are stoma- or bowel-related in addition to other symptom burden such as pain, fatigue, and existential distress that have deleterious consequences on their psychological and social functioning. This pilot study aims to test an intervention for patients specifically with advanced colorectal cancer that incorporates culturally-appropriate topics. Using a randomized selection design, we will investigate the feasibility and acceptability of the intervention and obtain an initial estimate of efficacy of the intervention. This pilot study will yield useful information to inform the preparation of a larger, phase III confirmatory study.
Cancer is the leading cause of death in Singapore and colorectal cancer is the most
frequently diagnosed cancer in males and second most frequently diagnosed cancer in females,
accounting for 17% and 13% of all cancers respectively. Such high incidence rates are
consistent with reports of colorectal cancer being a disease of ageing and developed nations
. A total of 8931 new cases of colorectal cancer were diagnosed in Singapore from 2009 and
2013, with data indicating a steep increase in incidence rate for patients aged 50 and above.
Given that the number of adults aged 65 years and older to double from 2009 to 2030
(Singapore Department of Statistics), the number of colorectal cancer cases are also expected
to increase.
Advanced colorectal cancer refers to stage IV cancer of the colon or rectum that cannot be
cured and has metastasized to at least one distant organ or set of lymph nodes, and that will
likely continue to spread, leading to end of life (National Cancer Institute). In Singapore
between 2009 and 2013, approximately 25% of colorectal cancer cases were at stage IV.
According to the U.S. NCI's SEER database of patients from 2004-2010, 5-year survival rates
for stage IV colon and rectal cancer were 11% and 12% respectively, suggesting these patients
are or will soon be managing symptoms of their disease like pain while psychologically
confronting end-of-life.
The news of metastatic disease, treatment failure, and/or bleak prognosis can be demoralizing
for some patients and characterized by shock, denial, anger, anxiety, and depression which
can interfere with everyday living. Studies have reported about one-third to half of advanced
cancer patients experience psychological distress and existential crises, yet studies
indicate the needs of these patients are not properly assessed and addressed as healthcare
providers tend to focus more on patients' physical problems and do not have the time and
perceived competency to address emotional distress.
Colorectal cancer comes with its own set of challenges that can significantly alter patients'
daily living and affect patient psychological well-being and quality of life. Bowel-related
issues have been reported to present physical, psychological, and social challenges to
patients and survivors. For instance, patients with surgically-created stoma as part of
treatment may face complications of leakage, skin, and odour issues that can lead to anxiety,
disturbance in body image, low self-esteem, and social isolation. Furthermore, clinical
anecdotes have pointed toward this patient population being concerned about lifestyle factors
influencing their disease progression, especially diet. Psychological care has been
increasingly recognized as an important part of treatment for this population at such a
vulnerable time. Psychological care aims to address patients' mood and worries as they deal
with their illness and to help patients find a sense of meaning in their life despite their
cancer-related suffering. Unfortunately, psychological care as part of oncology supportive/
palliative services is still very rudimentary in Singapore.
Cognitive behavioural therapy is a widely used, evidence-based therapy that focuses on
cognitions, emotions, and behaviour change to address patient distress. This framework has
been successfully applied in the treatment of many disorders, including anxiety disorders,
depression, chronic pain, and insomnia. It is posited that psycho-behavioural interventions
(PBIs) that are based on cognitive-behavioural frameworks can be designed to meet the needs
of cancer patients by targeting and modifying their maladaptive thoughts about the disease
and treatment (e.g., irrational beliefs, negative attitudes, unrealistic expectations) and
their behaviour (e.g., maladaptive coping strategies, isolation, self-negligence). This can
be done by teaching patients strategies such as cognitive restructuring, meaning-making,
relaxation, activity-pacing, effective communication with others, and utilization of social
support. By learning these skills, patients are expected to have increased health-related
self-efficacy (i.e., belief in the capacity to manage one's health) that may act as a buffer
from them prematurely adopting the "sick role". Self-efficacy can be extremely important in
the context of advanced cancer as it allows patients to feel more in control of a situation
that is often distressing because of the uncertainty associated with the illness. This in
turn may have an effect on patient psychological well-being, symptom management, and
utilization of healthcare services such as emergency department (ED) visits and inpatient
hospitalizations.
The efficacy of PBIs in alleviating physical symptoms in early-stage cancer has been
well-documented. However, the role of such intervention for advanced cancer patients is less
clear due to lack of well-designed studies. Advanced disease has unique challenges; for
instance, more severe physical symptoms and confrontation of existential meaning as patients
approach end of life. This can be associated with greater distress and suffering for
patients. A recent review noted that interpretation of the efficacy/effectiveness of PBIs for
advanced cancer is limited by the paucity of randomized-controlled studies and lack of
racial/ethnic diversity in patients.
The current study aims to investigate the feasibility and acceptability of a PBI designed for
advanced colorectal patients implemented in a Singapore context. The intervention will be
facilitated by clinical psychologists whose specialty area is psycho-oncology, so as to allow
in-depth discussions about suffering associated with cancer and confrontation of end-of-life
issues. In this early phase trial, we think it is prudent to conduct the pilot intervention
with a homogeneous cancer site so that we can teach symptom management skills that are
specific to colorectal cancer. Additionally, we prefer to keep the disease characteristics,
prognosis, and indicated treatments as similar as possible across our sample. Such
homogeneity prevents the dilution of the intervention effects and facilitates the aim of
obtaining an initial estimate of intervention efficacy. The intervention will be unique in
that it will include a) therapeutic discussion on legacy building as a way to open discussion
about fear of death; b) addressing changed family dynamics, which is important in an Asian
context, and c) discussing adaptation to living with bowel-related issues that are a common
cause of distress for this patient population. It will be important to use a
randomized-controlled design, which is the gold-standard, to provide a definitive answer on
the role of PBIs for advanced cancer patients.
In summary, the significance of the study is twofold. Firstly, the proposed PBI pilot study
will provide essential, useful information on feasibility and acceptability of providing
low-cost, psychological care to advanced colorectal cancer patients that have the potential
to address their distress and reduce unnecessary healthcare utilization in Singapore.
Secondly, this would be an opportunity to add to the larger body of knowledge on the role of
PBIs in provision of supportive care in an Asian setting and beyond. The results will be
informative in deciding the worthiness of a phase III confirmatory study. Patients require
support throughout the course of their cancer treatment, and currently there are gaps in
provision of psychological care for patients with advanced cancer in Singapore's healthcare
system. Our long-term goal is to implement evidence-based, cost-effective and scalable
psychosocial support as a standard part of supportive care in Singapore.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04552093 -
Hepatic Arterial Infusion Pump Chemotherapy Combined With Systemic Chemotherapy (PUMP-IT)
|
Phase 2/Phase 3 | |
| Completed |
NCT04192565 -
A Prospective Investigation of the ColubrisMX ELS System
|
N/A | |
| Completed |
NCT05178745 -
A Prospective Observational Cohort Study Evaluating Resection Rate in Patients With Metastatic Colorectal Cancer Treated With Aflibercept in Combination With FOLFIRI - Observatoire résection
|
||
| Recruiting |
NCT03561350 -
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
|
||
| Recruiting |
NCT06128798 -
Effect of Preoperative Immunonutrition Versus Standard Oral Nutrition in Patient Undergoing Colorectal Surgery.
|
N/A | |
| Recruiting |
NCT03602677 -
Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage
|
N/A | |
| Completed |
NCT03631407 -
Safety and Efficacy of Vicriviroc (MK-7690) in Combination With Pembrolizumab (MK-3475) in Participants With Advanced/Metastatic Microsatellite Stable (MSS) Colorectal Cancer (CRC) (MK-7690-046)
|
Phase 2 | |
| Withdrawn |
NCT04192929 -
Chromoendoscopy or Narrow Band Imaging (NBI) for Improving Adenoma Detection in Colonoscopy
|
N/A | |
| Recruiting |
NCT03042091 -
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
|
Early Phase 1 | |
| Terminated |
NCT02842580 -
De-escalation Chemotherapies Versus Escalation in Non Pre-treated Unresectable Patients With Metastatic Colorectal Cancer
|
Phase 2 | |
| Completed |
NCT02889679 -
Underwater Resection of Non-pedunculated Colorectal Lesions
|
N/A | |
| Completed |
NCT02564835 -
Effects of Yoga on Cognitive and Immune Function in Colorectal Cancer
|
N/A | |
| Completed |
NCT02149108 -
Nintedanib (BIBF 1120) vs Placebo in Refractory Metastatic Colorectal Cancer (LUME-Colon 1)
|
Phase 3 | |
| Completed |
NCT02503696 -
Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)
|
N/A | |
| Completed |
NCT02599103 -
The Effects of Various Cooking Oils on Health Related Biomarkers in Healthy Subjects
|
N/A | |
| Completed |
NCT01719926 -
Phase I Platinum Based Chemotherapy Plus Indomethacin
|
Phase 1 | |
| Completed |
NCT01669109 -
Hatha Yoga for Patients With Colorectal Cancer
|
N/A | |
| Recruiting |
NCT01428752 -
Study of Prevalence of Colorectal Adenoma in 30- to 49-year-old Subjects With a Family History of Colorectal Cancer
|
N/A | |
| Completed |
NCT01978717 -
General Anesthesia Combined With Epidural Anesthesia Mitigates the Surgical Stress-related Immunosuppression in Patients With Colorectal Cancer
|
N/A | |
| Completed |
NCT01877018 -
Colorectal Cancer Screening in Primary Care
|
N/A |